Suppliers / Glaxosmithkline Brasil Ltda

Glaxosmithkline Brasil Ltda

Brazil 229 employees Updated 9 July 2026

Glaxosmithkline Brasil Ltda is a finished-dose manufacturer based in Brazil. It appears in 593 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with ANVISA (Brazil), INHRR (VE) and ARCSA (EC). Its GMP standing is certified by ANVISA (Brazil).

0
active US DMFs
0
valid CEPs
1
registered plants
593
filings across 6 regulators

Registered plants

Site FDA FEI
RIO DE JANEIRO, Brazil Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
ANVISA (Brazil) 555 2
INHRR (VE) 19 None
ARCSA (EC) 8 None
ISP (CL) 6 None
MINSA (CR) 4 None
EEC_EAEU 1 None

Questions about Glaxosmithkline Brasil Ltda

Does Glaxosmithkline Brasil Ltda hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Glaxosmithkline Brasil Ltda. It does have 593 filings with 6 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Glaxosmithkline Brasil Ltda manufacture?
1 registered site is on record, in Brazil (RIO DE Janeiro). Every site is listed on this page with the register it came from.
Which regulators recognise Glaxosmithkline Brasil Ltda's GMP?
Current GMP certificates are on record from ANVISA (Brazil). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Glaxosmithkline Brasil Ltda comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates